Table 3.
Values are presented as number (%).
U/M/L, upper/middle/lower; E/D, elevated/depressed; A/Di/Un, adenoma/differentiated adenocarcinoma/undifferentiated adenocarcinoma.
aFive patients had both synchronous and metachronous cancers. They are grouped with the metachronous lesion subgroup.